@article{c13e82388d9f454c8f33cc8c24048072,
title = "Overtreatment of low-risk patients with atrial fibrillation - The quality coin has 2 sides: Reply",
author = "Hsu, {Jonathan C.} and Maddox, {Thomas M.} and Marcus, {Gregory M.}",
note = "Funding Information: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Hsu reports receiving honoraria from Janssen Pharmaceuticals, Medtronic, and St Jude Medical and consulting fees from Celladon. Dr Marcus reports receiving research support from the National Institutes of Health, Patient-Centered Outcomes Research Institute, Medtronic, Pfizer, Rhythm Diagnostic Systems, and SentreHeart; he is a consultant for and has equity ownership in InCarda.",
year = "2016",
month = oct,
doi = "10.1001/jamacardio.2016.2273",
language = "English",
volume = "1",
pages = "849",
journal = "JAMA Cardiology",
issn = "2380-6583",
number = "7",
}